Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Amylyx Pharmaceuticals Inc.
Sponsor

Amylyx Pharmaceuticals Inc.

United States 43 Thorndike Street, 02141-1764, United States

About the sponsor

Clinical research activity includes ALS with attention to disease progression, functional decline, and treatment effects in adult patients.

  • Disease progression in amyotrophic lateral sclerosis
  • Functional outcomes in motor neuron disease
  • Therapeutic evaluation of AMX0035

The sponsor’s work in this area centers on neurological conditions marked by progressive loss of motor function and disability.

About Specializations

Amylyx Pharmaceuticals Inc. runs clinical trials in conditions such as Amyotrophic lateral sclerosis, Progressive supranuclear palsy, among others.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

2 clinical trials

Amyotrophic lateral sclerosis

Not recruiting
Investigational
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Phenylbutyrate
  • Sponsor:Amylyx Pharmaceuticals Inc.

Progressive supranuclear palsy

Not recruiting
Investigational
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Phenylbutyrate
  • Sponsor:Amylyx Pharmaceuticals Inc.

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.